Question

You are evaluating to make an investment in a small biotech start-up which will require an...

You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.8 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years (the period of the patent) and zero after that. If the insurance companies decide to cover the drug, the start-up will be able to generate free cash flows of $800,000 during the next 12 years (the period of the patent) and zero after that. Furthermore, the start-up can also decide to sell the patent to a larger biotech company for $2.5 million after knowing the answer of the insurance companies (end of year 1), whether they cover it or not. You expect that the insurance companies will approve the drug with a 70% probability and you require a 20% return. What is the NPV of the investment?”

Homework Answers

Answer #1

If the project is covered

NPV = 1326144.48

Probability = 0.7

Net NPV = 928301.14

In case project is not approved

NPV = -153594.42

Probability = 0.3

Net NPV = -46078.33

Total NPV = 928301.14 - 46078.33 = 882222.81

LET ME KNOW IF YOU HAVE ANY DOUBTS

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.0 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.5 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.5 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.1 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be cover in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.0 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.2 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.0 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $1.3 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating to make an investment in a small biotech start-up which will require an...
You are evaluating to make an investment in a small biotech start-up which will require an investment of $2.0 million. The start-up is expecting to generate free cash flows of $200,000 during the first year. After one year, the insurance companies will decide if the start-up’s drug will be covered in their plans or not. If they decide to not cover the drug, the company will be able to generate free cash flows of $400,000 during the next 12 years...
You are evaluating a project that will require an initial investment of $200. Over the next...
You are evaluating a project that will require an initial investment of $200. Over the next four years, the project is expected to generate after-tax cash flows of 40, 50, 60, 70. If 8% is your appropriate discount rate, what is the NPV and IRR of this project? Choices: 21.02, 9.20% 33.67, 10.03% 41.55, 11.88% -10.55, 6.65% -21.02, 3.58%